Seminoma
A radiosensitive, malignant neoplasm of the testis, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. There are three variants: classical (typical), the most common type; anaplastic; and spermatocytic. The classical seminoma is composed of fairly well differentiated sheets or cords of uniform polygonal or round cells (seminoma cells), each cell having abundant clear cytoplasm, distinct cell membranes, a centrally placed round nucleus, and one or more nucleoli. In the female, a grossly and histologically identical neoplasm, known as dysgerminoma, occurs. (Dorland, 27th ed)
Drugs by status
Organizations
Organization Involved with Phase 3 Indications (23)
- Medical Research Council
- National Cancer Institute (NCI)
- Aarhus University
- Cancer Research UK
- University of London
- Cornell University
- Lund University
- Norwegian University of Science and Technology
- Osaka University
- University Hospital of North Norway
- UNICANCER
- University of Bergen
- Uppsala University
- Royal Marsden Hospital NHS Trust
- Karolinska Institute
- European Organisation for Research and Treatment of Cancer
- University of Gothenburg
- Linkoping University
- Norrlands University
- Movember Foundation
- Irish Group CTI
- Barts & The London NHS Trust
- Simbec-Orion
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (1)